Literature DB >> 3351679

Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening.

Y Hayashi1, T Inaba, R Hanada, K Yamamoto.   

Abstract

We performed chromosome analysis of 15 neuroblastomas found by mass screening using a vanillymandelic acid spot test. We found near triploid chromosome abnormalities, ranging from 60 to 77 chromosomes, in the tumor cells from 14 patients, and hyperdiploidy with the mode of 50 in cells from one. A structural abnormality was observed in only one patient. We did not find a marker chromosome 1, homogeneously staining region, or double minutes, which have been previously reported in advanced neuroblastomas or in cell lines. All of our patients were completely free of disease 4 to 32 months after diagnosis. We consider that patients with hyperdiploidy or near triploidy are different from those with marker chromosome 1, homogeneously staining region, or double minutes and may constitute a subgroup with a good prognosis in childhood neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3351679     DOI: 10.1016/s0022-3476(88)80168-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Screening for neuroblastoma.

Authors:  G J Draper
Journal:  BMJ       Date:  1988-07-16

Review 2.  Biology of tumors of the peripheral nervous system.

Authors:  G M Brodeur; J F Moley
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

3.  Poor prognosis neuroblastoma: is screening the answer?

Authors:  A W Craft; L Parker
Journal:  Br J Cancer Suppl       Date:  1992-08

4.  How frequent is spontaneous remission of neuroblastomas? Implications for screening.

Authors:  N L Carlsen
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

5.  Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas.

Authors:  David Gisselsson; Gisela Lundberg; Ingrid Ora; Mattias Höglund
Journal:  J Carcinog       Date:  2007-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.